Bludigo Injection
Product Images NDC 81284-315

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bludigo (NDC 81284-315). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Provepharm Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Ic1)

Chemical structure of indigotindisulfonate sodium, shown as a symmetrical molecule with sulfonate groups (NaO3S) attached to each benzene ring.*

FDA Label Image

Carton Label (Ic3)

Packaging label for Bludigo (indigotindisulfonate sodium) Injection, USP, 40 mg/5 mL (8 mg/mL) intravenous injection. The label indicates a package of 5 single-dose 5 mL ampules. Manufactured by CENEXI, France, and distributed by Provepharm Inc., the design includes purple and white color blocks with dosing information and storage instructions.*

FDA Label Image

Vial Label (Ic4)

Label for Bludigo (indigotindisulfonate sodium) Injection, USP, 40 mg/5 mL (8 mg/mL) intravenous single-dose ampule. Manufactured by CENEXI for Provepharm SAS and distributed by Provepharm, Inc., Collegeville, PA. Includes NDC 81284-315-00 and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.